Search results
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 56 minutes agoThere's a new approach that people are trying, which is called an RNA vaccine, which is what this ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 6 days agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 day agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 2 hours agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 6 days agoThe FDA has informed Moderna that it is working to conclude...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 4 hours agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 6 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 11 hours agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...